Structures of lipoprotein signal peptidase II from Staphylococcus aureus complexed with antibiotics globomycin and myxovirescin
Research output: Contribution to journal › Article › peer-review
Colleges, School and Institutes
- Trinity College Dublin
- Paul Scherrer Institute
- University of Saarland, Saarbrucken, Germany.
Antimicrobial resistance is a major global threat that calls for new antibiotics. Globomycin and myxovirescin are two natural antibiotics that target the lipoprotein-processing enzyme, LspA, thereby compromising the integrity of the bacterial cell envelope. As part of a project aimed at understanding their mechanism of action and for drug development, we provide high-resolution crystal structures of the enzyme from the human pathogen methicillin-resistant Staphylococcus aureus (MRSA) complexed with globomycin and with myxovirescin. Our results reveal an instance of convergent evolution. The two antibiotics possess different molecular structures. Yet, they appear to inhibit identically as non-cleavable tetrahedral intermediate analogs. Remarkably, the two antibiotics superpose along nineteen contiguous atoms that interact similarly with LspA. This 19-atom motif recapitulates a part of the substrate lipoprotein in its proposed binding mode. Incorporating this motif into a scaffold with suitable pharmacokinetic properties should enable the development of effective antibiotics with built-in resistance hardiness.
|Number of pages||11|
|Early online date||9 Jan 2020|
|Publication status||Published - Dec 2020|
- Aspartic Acid Endopeptidases/metabolism, Bacterial Proteins/metabolism, Binding Sites/physiology, Cell Membrane/drug effects, Crystallography, X-Ray, Drug Resistance, Bacterial/genetics, Macrolides/metabolism, Methicillin-Resistant Staphylococcus aureus/enzymology, Peptides/metabolism, Protein Binding/physiology, Protein Structure, Tertiary